Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) EBIT Margin (2020 - 2025)

Historic EBIT Margin for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to 2655.19%.

  • iSpecimen's EBIT Margin fell 25911300.0% to 2655.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 361.81%, marking a year-over-year decrease of 2678900.0%. This contributed to the annual value of 136.99% for FY2024, which is 244900.0% down from last year.
  • As of Q3 2025, iSpecimen's EBIT Margin stood at 2655.19%, which was down 25911300.0% from 255.41% recorded in Q2 2025.
  • In the past 5 years, iSpecimen's EBIT Margin registered a high of 31.81% during Q1 2021, and its lowest value of 2655.19% during Q3 2025.
  • In the last 5 years, iSpecimen's EBIT Margin had a median value of 93.64% in 2022 and averaged 254.81%.
  • As far as peak fluctuations go, iSpecimen's EBIT Margin soared by 1429900bps in 2024, and later crashed by -25911300bps in 2025.
  • iSpecimen's EBIT Margin (Quarter) stood at 78.26% in 2021, then increased by 8bps to 72.31% in 2022, then crashed by -54bps to 111.49% in 2023, then plummeted by -255bps to 395.83% in 2024, then tumbled by -571bps to 2655.19% in 2025.
  • Its EBIT Margin was 2655.19% in Q3 2025, compared to 255.41% in Q2 2025 and 154.93% in Q1 2025.